Ending the Pandemic
“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” […]
Entries by Morgana Souza
BIOQUAL Announces COVID-19 Vaccine Testing
BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan […]
WBUR’s All Things Considered Broadcast: March 30, 2020
Dr. Dan Barouch speaks with Lisa Mullins from WBUR about COVID-19 vaccine plans with Johnson & Johnson. Listen more
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
[pdf-embedder url=”https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/JNJ-BARDA-Press-Release-3-30-20.pdf” title=”JNJ BARDA Press Release 3-30-20″]
US and J & J commit $1b to coronavirus vaccine codeveloped by Beth Israel
Clinical trials are set to start by September, and if all goes well, it could be ready for emergency use early next year. Read Article
Here are some of the Mass. businesses and institutions on the front lines of the COVID-19 battle
“The industry in Massachusetts is going to the mat to fight this thing.” Read Article
How Does the Coronavirus Behave Inside a Patient?
“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and […]
Beth Israel Launches Drug Study to Help COVID-19 Patients
Dr. Katy Stephenson speaks to NBC Boston about leading two clinical trials for a treatment for COVID-19 patients. See more
New clinical trials underway to evaluate antiviral drug as treatment for COVID-19
Dr. Katy Stephenson, physician-scientists at Harvard Medical School and Beth Israel Deaconess Medical Center are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused […]
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells
Pre-conference Community HIV Cure Research Workshop outlines the results. Read Article
